Argus Research Maintains Buy on Rithm Capital, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst Kevin Heal maintains a Buy rating on Rithm Capital (RITM) and raises the price target from $11 to $12.
March 05, 2024 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research has maintained a Buy rating on Rithm Capital and increased the price target from $11 to $12.
The upgrade in the price target by a reputable analyst firm like Argus Research typically signals a positive outlook on the stock, suggesting potential upside. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100